FV van Venrooij, MA van de Ree, ML Bots, RP Stolk … - Diabetes Care, 2002 - Am Diabetes Assoc OBJECTIVE—Endothelial dysfunction is considered an important early marker of atherosclerosis and
cardiovascular risk and is currently used as a surrogate end point for cardiovascular risk in
clinical trials. Type 2 diabetic ... Cited by 66 - Related articles - BL Direct - All 6 versions
WH Sheu, BL Juang, YT Chen, WJ Lee - Diabetes Care, 1999 - Am Diabetes Assoc Anumber of diabetes-specific quality of life measures have been developed (1–4). However, the
majority of the measu res were originally developed in English for use in English-speaking coun-
tries (5). Given the rapid growth ... Cited by 46 - Related articles - BL Direct - All 5 versions
ML Bots, RP Stolk, MV Huisman, JD Banga - Diabetes Care, 2002 - Am Diabetes Assoc OBJECTIVE — Endothelial dysfunction is considered an important early marker of athero- sclerosis
and cardiovascular risk and is currently used as a surrogate end point for cardiovascular risk in
clinical trials. Type 2 diabetic ... Related articles
- ►oxfordjournals.org MA van de Ree, MV Huisman, FH de … - Cardiovascular …, 2001 - cardiovascres.oxfordjournals.org The endothelial dysfunction has been proven to be a predictor for future cardiovascular events
[1,2]. Acute hyperglycemia and acute hyperinsulinemia tested in clamp studies have been found to
impair the endothelial function in ... Cited by 68 - Related articles - All 6 versions
- ►ahajournals.org RW van Etten, EJP de Koning, ML Honing, ES … - … , and vascular biology, 2002 - Am Heart Assoc Cardiovascular disease is the most important cause of morbidity and mortality in patients with type
2 diabetes. Endothelial dysfunction predicts cardiovascular outcome. Type 2 diabetes is
characterized by endothelial ... Cited by 71 - Related articles - BL Direct - All 9 versions
- ►europa-trial.com [PDF] ML Bots, WJ Remme, TF Lüscher, DE Grobbee - Cardiovascular Drugs and …, 2002 - Springer Cardiovascular Drugs and Therapy 16 227–236 2002 C 2002 Kluwer Academic Publishers. Manufactured
in The Netherlands ... PERindopril—Function of the Endothelium in Coronary ... Artery Disease
Trial: The PERFECT Study—Sub Study Cited by 19 - Related articles - BL Direct - All 7 versions
- ►endojournals.org PA Economides, A Caselli, E Tiani, L Khaodhiar … - Journal of Clinical …, 2004 - Endocrine Soc ENDOTHELIAL FUNCTION IS abnormal in both the macro- and microcirculation in subjects with type 1 or
type 2 diabetes mellitus (1, 2, 3). Furthermore, endothelial function is impaired in healthy
subjects who are at risk of ... Cited by 70 - Related articles - BL Direct - All 4 versions
- ►diabetesjournals.org [PDF] WHH Sheu, YT Chen, WJ Lee - Diabetes Care, 2001 - Am Diabetes Assoc Animal studies have demonstrated lower levels of 1,25(OH)2D3 in a type 2 diabetes model compared
with controls (1). Alterations in circulat- ing vitamin D3 metabolites, such as de- creased
1-hydroxylase activity and enhanced ... Cited by 15 - Related articles - BL Direct - All 4 versions
- ►endojournals.org KCB Tan, WS Chow, SCF Tam, VHG Ai, CHL … - Journal of Clinical …, 2002 - Endocrine Soc Endothelial dysfunction is frequently found in diabetic subjects. This study was performed to
investigate whether atorvastatin therapy was able to reverse endothelial dysfunction in type 2
diabetes and, if so, whether the ... Cited by 149 - Related articles - BL Direct - All 5 versions
- ►sinoas.com [PDF] HW Wilmink, MJJ de Kleijn, ML Bots, AAA Bak, YT van … - Atherosclerosis, 2000 - Elsevier Background. Lipoprotein (a) (Lp(a)) is an independent risk factor for atherosclerotic cardiovascular
disease. The atherogenic potential of Lp(a) may be by impairment of endothelial function.
Objectives. We investigated the ... Cited by 25 - Related articles - All 10 versions
